Cargando…

Castleman's disease with TAFRO syndrome: a case report from Syria

Castleman's disease is a rare disorder, yet a rarer newly described syndrome called TAFRO syndrome was discovered to accompany it. TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly). Most cases were described in Japan. We pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhoulaiby, Sami, Ahmad, Basel, Alrstom, Ali, Kudsi, Mayssoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451894/
https://www.ncbi.nlm.nih.gov/pubmed/28580156
http://dx.doi.org/10.1093/omcr/omx021
_version_ 1783240269402996736
author Alhoulaiby, Sami
Ahmad, Basel
Alrstom, Ali
Kudsi, Mayssoun
author_facet Alhoulaiby, Sami
Ahmad, Basel
Alrstom, Ali
Kudsi, Mayssoun
author_sort Alhoulaiby, Sami
collection PubMed
description Castleman's disease is a rare disorder, yet a rarer newly described syndrome called TAFRO syndrome was discovered to accompany it. TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly). Most cases were described in Japan. We present the first case of TAFRO syndrome in Syria. A 58-year-old Caucasian male with no relevant history presented with fatigue, oliguria, decreased platelets, increased creatinine level, hepatosplenomegaly, ascites, pitting edema and lymph node enlargement. Possible differential diagnoses were excluded by laboratory, radiologic and cytologic tests including TB, malignancy and autoimmune diseases. A biopsy of a supraclavicular lymph node confirmed Castleman disease. Our patient had Catleman's disease, and presented with only four diagnostic criteria for TAFRO syndrome (Myelofibrosis was absent) in addition to other minor characteristics (microcytic anemia, negative HIV and HHV-8 infections.) which make the presentation consistent with TAFRO syndrome described in the Japanese cases. The criteria for diagnosing TAFRO syndrome are still changing, and the pathophysiology behind it is unclear. We recommend further research to understand this syndrome taking into account that its prevalence might be worldwide.
format Online
Article
Text
id pubmed-5451894
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54518942017-06-02 Castleman's disease with TAFRO syndrome: a case report from Syria Alhoulaiby, Sami Ahmad, Basel Alrstom, Ali Kudsi, Mayssoun Oxf Med Case Reports Case Report Castleman's disease is a rare disorder, yet a rarer newly described syndrome called TAFRO syndrome was discovered to accompany it. TAFRO represents the constellation of symptoms (Thrombocytopenia, Anasarca, MyeloFibrosis, Renal failure, Organomegaly). Most cases were described in Japan. We present the first case of TAFRO syndrome in Syria. A 58-year-old Caucasian male with no relevant history presented with fatigue, oliguria, decreased platelets, increased creatinine level, hepatosplenomegaly, ascites, pitting edema and lymph node enlargement. Possible differential diagnoses were excluded by laboratory, radiologic and cytologic tests including TB, malignancy and autoimmune diseases. A biopsy of a supraclavicular lymph node confirmed Castleman disease. Our patient had Catleman's disease, and presented with only four diagnostic criteria for TAFRO syndrome (Myelofibrosis was absent) in addition to other minor characteristics (microcytic anemia, negative HIV and HHV-8 infections.) which make the presentation consistent with TAFRO syndrome described in the Japanese cases. The criteria for diagnosing TAFRO syndrome are still changing, and the pathophysiology behind it is unclear. We recommend further research to understand this syndrome taking into account that its prevalence might be worldwide. Oxford University Press 2017-06-01 /pmc/articles/PMC5451894/ /pubmed/28580156 http://dx.doi.org/10.1093/omcr/omx021 Text en © The Author 2017. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Alhoulaiby, Sami
Ahmad, Basel
Alrstom, Ali
Kudsi, Mayssoun
Castleman's disease with TAFRO syndrome: a case report from Syria
title Castleman's disease with TAFRO syndrome: a case report from Syria
title_full Castleman's disease with TAFRO syndrome: a case report from Syria
title_fullStr Castleman's disease with TAFRO syndrome: a case report from Syria
title_full_unstemmed Castleman's disease with TAFRO syndrome: a case report from Syria
title_short Castleman's disease with TAFRO syndrome: a case report from Syria
title_sort castleman's disease with tafro syndrome: a case report from syria
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451894/
https://www.ncbi.nlm.nih.gov/pubmed/28580156
http://dx.doi.org/10.1093/omcr/omx021
work_keys_str_mv AT alhoulaibysami castlemansdiseasewithtafrosyndromeacasereportfromsyria
AT ahmadbasel castlemansdiseasewithtafrosyndromeacasereportfromsyria
AT alrstomali castlemansdiseasewithtafrosyndromeacasereportfromsyria
AT kudsimayssoun castlemansdiseasewithtafrosyndromeacasereportfromsyria